Abundant tyrosine residues in the antigen binding site in anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: Application to radiolabeling

Acta Oncologica

Volumn 35, Issue 3, 1996, Pages 297-301

  Olafsen, Tove ^a   Bruland, Øyvind S ^b   Zalutsky, Michael R ^c   Sandlie, Inger ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY I 131;

ANTIGEN BINDING; BINDING SITE; CANCER IMMUNOTHERAPY; CONFERENCE PAPER; DIAGNOSTIC VALUE; GENE AMPLIFICATION; HUMAN; IMMUNOGLOBULIN GENE; ISOTOPE LABELING; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BINDING SITES, ANTIBODY; CLONING, MOLECULAR; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; IODINE RADIOISOTOPES; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; TYROSINE;

EID: 0029892885     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609101644     Document Type: Article

References (32)

1. Link MP, Goorin Am, Horowitz M, et al. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop 1991; 270: 8-14.
2. Bruland ØS, Pihl A. Immunoscintigraphy and radioimmunotherapy. Useful approaches in the management of osteogenic sarcoma? In: Novak J. ed. Frontiers of osteosarcoma research. Hogrefe & Huber (ISBN 0-88937-113-x), 1993: 149-59.
3. Kleinerman ES, Maeda M, Jaffe N. Liposome-encapsulated muramyl tripeptide: a new biologic response modifier for the treatment of osteosarcoma. Cancer Treat Res 1993; 62: 101-7.
4. Bruland ØS, Fodstad Ø, Funderud S, Pihl A. New monoclonal antibodies specific for human sarcomas. Int J Cancer 1986; 38: 27-31.
5. Bruland ØS, Fodstad Ø, Stenwig AE, Pihl A. Expression and characteristics of a novel human osteosarcoma-associated cell surface antigen. Cancer Res 1988; 48: 5302-9.
6. Haines DM, Bruland ØS. Immunohistochemical detection of osteosarcoma-associated antigen in canine osteosarcoma. Anticancer Res 1989; 9: 903-7.
7. Bruland ØS, Fodstad Ø, Skretting A, Pihl A. Selective localisation of two radiolabeled antisarcoma monoclonal antibodies in human osteosarcoma xenografts. Br J Cancer 1987; 56: 21-5.
8. Fjeld JG, Bruland ØS, Benestad HB, Schjerven L, Stigbrand T, Nustad K. Radio-immunotargeting in immunocompetent animals using intraperitoneal diffusion chambers containing human tumor cells. Br J Cancer 1990; 62: 573-8.
9. 2 fragments of osteosarcoma-associated monoclonal antibody TP-1. Anticancer Res 1992; 12: 2151-7.
10. Page RL, Garg PK, Garg S, Archer GE, Bruland ØS, Zalutsky MR. PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment. J Nucl Med 1994; 35: 1506-13.
11. Bruland ØS, Fodstad Ø, Aas M, et al. Immunoscintigraphy of bone sarcomas - results in 5 patients. Eur J Cancer 1994; 30A, 1484-9.
12. Colcher D, Bird R, Roselli M, et al. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J Natl Cancer Inst 1990; 82: 1191-7.
13. Adams GP, McCartney JE, Tai MS, et al. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv. Cancer Res 1993; 53: 4026-34.
14. Yokota T, Milenic DE, Whitlow M, Schlom J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 1992; 52: 3402-8.
15. Pietersz GA, Rowland A, Smyth MJ, McKenzie IF. Chemoimmunoconjugates for the treatment of cancer. Adv Immunol 1994; 56: 301-87.
16. Olafsen T, Bruland ØS, Zalutsky MR, Sandlie I. Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: Location of lysine residues and implications for radiolabeling. Nucl Med Biol 1995; 22: 765-71.
17. Orlandi R, Güssow DH, Jones PT, Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 3833-7.
18. Messing J. New M13 vectors for cloning. Methods Enzymol 1983; 101: 20-78.
19. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7.
20. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucl Acids Res 1984; 12: 387-95.
21. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of proteins of immunological interest. 5th ed., Publich Health Service, NIH Washington DC, 1991.
22. Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987; 196: 901-17.
23. Chothia C, Lesk AM, Tramontano A, et al. Conformations of immunoglobulin hypervariable regions. Nature 1989; 342: 877-83.
24. Smith-Gill SJ, Mainhart C, Lavoie TB, Feldman RJ, Drohan W, Brooks BR. A three-dimensional model of an anti-lysozyme antibody. J Mol Biol 1987; 194: 713-24.
25. Padlan EA, Silverton EW, Sheriff S, Cohen GH, Smith-Gill SJ, Davies DR. Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci USA 1989; 86: 5938-42.
26. Abergel C, Tipper JP, Padlan EA. Structural significance of sequence variability in antibody complementarity-determining regions. Res Immunol 1994; 145: 49-53.
27. Padlan EA. Anatomy of the antibody molecule. Mol Immunol 1994; 31: 169-217.
28. Zalutsky, MR. Radiohalogenation of antibodies: chemical aspects. In: Srivastava SC, ed. Radiolabeled monoclonal antibodies for imaging and therapy. New York: Plenum Press, 1988: 195-212.
29. Seon BK, Roholt OA, Pressman D. Reactivity of tyrosine residues in the constant portion of type K Bence Jones protein. Biochim Biophys Acta 1970; 200: 81-8.
30. Dube SK, Roholt OA, Pressman D. Relative reactivity to iodination of tyrosine residues in alpha-chymtrypsin. J Biol Chem 1966; 241: 4665-9.
31. Schulz GE, Schirmer RH. Principles of protein structure. New York: Springer-Verlag, 1978.
32. Wolff J, Covelli I. Iodination of the normal and buried tyrosyl residues of lysozyme II. Spectrophotometric analysis. Biochemistry 1996; 5: 867-71.